{"id":"W2557010481","doi":"10.1182/blood.v124.21.800.800","title":"Ibrutinib Monotherapy in Relapsed/Refractory Follicular Lymphoma (FL): Preliminary Results of a Phase 2 Consortium (P2C) Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Tolerability; Mantle cell lymphoma; Oncology; Bruton's tyrosine kinase; Follicular lymphoma; Clinical endpoint; Lymphoma; Clinical trial; Chronic lymphocytic leukemia; Adverse effect; Leukemia; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00125313,0.0002662518,0.0007399732,0.0003116155,0.0000435259,0.00001425989,0.0002644802,0.0003018304,0.00007066752],"category_scores_gemma":[0.001468137,0.0002342512,0.0002299369,0.0004139734,0.0002267947,0.00006786358,0.00008304222,0.0002340608,0.00004946814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001250395,"about_ca_system_score_gemma":0.003830301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005684195,"about_ca_topic_score_gemma":0.00001868602,"domain_scores_codex":[0.9968503,0.0002911491,0.001001035,0.0005687836,0.000729347,0.0005593483],"domain_scores_gemma":[0.9975885,0.0006973673,0.0002840027,0.001045829,0.0001312589,0.0002530393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8598717,0.03870433,0.0003817419,0.0006129202,0.0007333913,0.001577185,0.002901903,0.00002821627,0.0373889,0.0002988257,0.003653259,0.05384761],"study_design_scores_gemma":[0.9223303,0.01181378,0.0005621752,0.0003054275,0.0001841874,0.0001890349,0.00009126586,0.002918804,0.05049407,0.00007902335,0.01079876,0.0002331725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927516,0.0008997998,0.00002762114,0.0002297651,0.0001799111,0.001445648,0.00002740937,0.00007159878,0.004366669],"genre_scores_gemma":[0.9976925,0.0001506504,0.0004449636,0.0001652644,0.0004098106,0.0001085351,0.00005121453,0.00005979612,0.0009172308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06245859,"threshold_uncertainty_score":0.9552485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02253585587394135,"score_gpt":0.3137643005637181,"score_spread":0.2912284446897768,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}